
Paclitaxel Injection - 260mg/43.4ml Clear Molded Glass Vial, Anticancer Treatment For Ovarian & Breast Cancer, Non-small Cell Lung Cancer, Aids-related Kaposi's Sarcoma
Price:
Get Latest Price
In Stock
Product Specifications
| Formulations Type | Injectables |
| Formulations Form | Powder |
| Treatments & Functions | Ovarian cancer: In first line chemotherapy of ovarian cancer, paclitaxel is indicated for the treatment of patients with advanced disease or a residual disease (> 1cm) after initial laparotomy, in combination with cisplatin. In second-line chemotherapy of ovarian cancer, paclitaxel is indicated in the treatment of metastatic carcinoma of the ovary after failure of standard platinum based therapy. Breast cancer: In the adjuvant setting, paclitaxel is indicated for the treatment of patients with node-positive breast carcinoma following anthracycline and cyclophosphamide (AC) therapy. Adjuvant treatment with paclitaxel should be regarded as an alternative to extended AC therapy. Paclitaxel is indicated for the initial treatment of locally advanced or metastatic breast cancer either in combination with an anthracycline in patients for whom anthracycline therapy is suitable, or in combination with trastuzumab, in patients who over-express human epidermal growth factor receptor 2 (HER-2) at a 3+ level as determined by immunohistochemistry and for whom an anthracycline is not suitable As a single agent, treatment of metastatic carcinoma of the breast in patients who have failed to respond adequately to standard treatment with anthracyclines or in whom anthracycline therapy has not been appropriate. Advanced non-small cell lung cancer (NSCLC): Paclitaxel, in combination with cisplatin, is indicated for the treatment of non-small cell lung cancer in patients who are not candidates for potentially curative surgical intervention and/or radiation therapy. AIDS-related Kaposi's sarcoma (KS): Paclitaxel is indicated for the treatment of patients with advanced AIDS-related Kaposi's sarcoma who have failed prior liposomal anthracycline therapy. |
| Certifications | WHO GMP APPROVEDPHARMACY & PPOISONS BOARD, KENYADepartment of Drug Administration (DDA), Ministry of Health and Population (MOHP)/Government of Nepal (GoN)NATIONAL MEDICINES AND POISONS BOARD, REPUBLIC OF SUDANMINISTERY OF PUBLIC HEALTH & POPULATION, REPUBLIC OF YEMEN |
Product Overview
Key Features
Company Details
Focusing on a customer-centric approach, Admac Lifesciences has a pan-India presence and caters to a huge consumer base throughout the country. Buy Common Medicines & Drugs in bulk from Admac Lifesciences at Trade India quality-assured products.
Business Type
Exporter, Manufacturer, Supplier
Establishment
1985
Working Days
Monday To Sunday
Payment Mode
Cash on Delivery (COD), Cash Advance (CA)
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
Panchkula, Haryana
Marketing Manager
Ms. Paramjeet Kaur
Address
Corporate Office, Admac House, Sco 84, Sector 5. Panchkula, Haryana, 134112, India
Report incorrect details









































